Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Peptide receptor radionuclide therapy (PRRT) of somatostatin receptor (SSTR) expressing neuroendocrine neoplasms (NEN) has shown promising results about progression free survival (PFS) and overall survival (OS) in numerous phase II trials, and also in a recently published randomized controlled prospective phase III study (NETTER-1).
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Kulkarni H
Authors: Baum R, Kulkarni H, Niepsch K, Kaemmerer D, Hommann M,
Introduction: Bulky disease from NET is an adverse prognostic factor for response to 177Lu-DOTA-octreotate (LuTate) PRCRT. 90Y-DOTA-octreotate (YTate) has more penetrating particulate emissions.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Kong G, Callahan J, Hofman M, Pattison D, Akhurst T,
Introduction: Peptide Receptor Radionuclide Therapy (PRRT) is an effective treatment option for advanced Neuroendocrine Tumours (NET), however long term survival data is lacking.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Yalchin M, Oliveira A, Pencharz D, Navalkissoor S, Quigley A,
Introduction: Peptide receptor radionuclide therapy (PRRT) is beneficial in well-differentiated neuroendocrine tumors (NETs).
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Kulkarni H
Authors: Baum R, Kulkarni H, Zachert C, Kaemmerer D, Petrovitch A,
Keywords: PRRT,
Introduction: Hepatic metastases significantly affect the overall prognosis and quality of life in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NET). Radiofrequency ablation (RFA) is one of the important local ablative strategies for hepatic metastases. Peptide receptor radionuclide therapy (PRRNT) is a well-established therapeutic modality for metastatic NET.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Kulkarni H, Kaemmerer D, Petrovich A, Hoersch D, Hommann M,
Keywords: Peptide receptor radionuclide therapy, radiofrequency ablation,